News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,321 Results
Type
Article (3076)
Company Profile (13)
Press Release (64232)
Multimedia
Podcasts (64)
Webinars (9)
Section
Business (16375)
Career Advice (325)
Deals (1849)
Drug Delivery (18)
Drug Development (4503)
Employer Resources (63)
FDA (654)
Job Trends (1559)
News (23259)
Policy (1102)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (1)
Academia (332)
Allergies (15)
Alliances (4795)
ALS (14)
Alzheimer's disease (212)
Antibody-drug conjugate (ADC) (11)
Approvals (664)
Artificial intelligence (129)
Autoimmune disease (6)
Automation (4)
Bankruptcy (9)
Best Places to Work (1433)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (9)
Bladder cancer (10)
Brain cancer (2)
Breast cancer (66)
Cancer (363)
Cardiovascular disease (35)
Career advice (284)
Career pathing (28)
CAR-T (14)
Cell therapy (49)
Cervical cancer (3)
Clinical research (3653)
Collaboration (189)
Compensation (16)
Complete response letters (1)
COVID-19 (159)
CRISPR (4)
C-suite (35)
Cystic fibrosis (16)
Data (418)
Decentralized trials (1)
Denatured (45)
Depression (5)
Diabetes (35)
Diagnostics (1285)
Digital health (7)
Diversity (9)
Diversity, equity & inclusion (19)
Drug discovery (25)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (3840)
Editorial (5)
Employer branding (10)
Employer resources (52)
Events (9458)
Executive appointments (123)
FDA (800)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (101)
Gene editing (7)
Generative AI (12)
Gene therapy (45)
GLP-1 (66)
Government (203)
Grass and pollen (1)
Guidances (8)
Healthcare (2247)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (9)
Indications (4)
Infectious disease (175)
Inflammatory bowel disease (22)
Inflation Reduction Act (6)
Influenza (10)
Intellectual property (2)
Interviews (53)
IPO (898)
IRA (6)
Job creations (134)
Job search strategy (212)
Labor market (35)
Layoffs (29)
Leadership (18)
Legal (126)
Liver cancer (9)
Lung cancer (28)
Lymphoma (30)
Machine learning (2)
Management (18)
Manufacturing (19)
MASH (17)
Medical device (1124)
Medtech (1125)
Mergers & acquisitions (1015)
Metabolic disorders (101)
Multiple sclerosis (12)
NASH (5)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (294)
NextGen: Class of 2025 (695)
Non-profit (596)
Northern California (374)
Now hiring (37)
Obesity (50)
Opinion (31)
Ovarian cancer (9)
Pain (11)
Pancreatic cancer (9)
Parkinson's disease (18)
Partnered (12)
Patents (15)
Patient recruitment (13)
Peanut (11)
People (7340)
Pharmaceutical (2)
Phase I (1140)
Phase II (1607)
Phase III (1219)
Pipeline (152)
Policy (12)
Postmarket research (155)
Preclinical (511)
Press Release (12)
Prostate cancer (14)
Psychedelics (2)
Radiopharmaceuticals (21)
Rare diseases (46)
Real estate (217)
Recruiting (17)
Regulatory (942)
Reports (42)
Research institute (411)
Resumes & cover letters (34)
Rett syndrome (1)
RNA editing (1)
RSV (2)
Schizophrenia (8)
Series A (18)
Series B (14)
Service/supplier (2)
Sickle cell disease (5)
Southern California (281)
Special edition (5)
Spinal muscular atrophy (11)
Sponsored (11)
Startups (343)
Stomach cancer (1)
Supply chain (1)
Tariffs (1)
The Weekly (18)
United States (3163)
Vaccines (48)
Venture capitalists (6)
Weight loss (17)
Women's health (17)
Worklife (16)
Date
Today (20)
Last 7 days (118)
Last 30 days (440)
Last 365 days (4881)
2025 (1623)
2024 (5074)
2023 (4933)
2022 (10416)
2021 (10156)
2020 (8031)
2019 (6035)
2018 (4105)
2017 (2618)
2016 (2290)
2015 (2480)
2014 (1606)
2013 (1255)
2012 (1334)
2011 (1182)
2010 (865)
Location
Africa (85)
Alabama (6)
Alaska (1)
Arizona (20)
Arkansas (1)
Asia (2273)
Australia (439)
California (814)
Canada (176)
China (32)
Colorado (33)
Connecticut (46)
Delaware (17)
Europe (8855)
Florida (97)
Georgia (23)
Idaho (5)
Illinois (73)
India (3)
Indiana (41)
Iowa (6)
Japan (19)
Kansas (4)
Louisiana (1)
Maine (26)
Maryland (91)
Massachusetts (606)
Michigan (14)
Minnesota (36)
Missouri (9)
Montana (4)
Nebraska (5)
Nevada (8)
New Hampshire (9)
New Jersey (236)
New Mexico (7)
New York (330)
North Carolina (164)
Northern California (374)
Ohio (33)
Oklahoma (2)
Oregon (19)
Pennsylvania (164)
Puerto Rico (1)
Rhode Island (4)
South America (83)
South Carolina (1)
South Dakota (1)
Southern California (281)
Tennessee (15)
Texas (125)
Utah (60)
Virginia (19)
Washington D.C. (5)
Washington State (88)
Wisconsin (8)
67,321 Results for "aster insights".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Aster Insights, ORIEN to Present Research Abstracts at the 60th ASCO Annual Meeting
Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, announced the company and members of the Oncology Research Information Exchange Network® will be presenting at the American Society of Clinical Oncology annual meeting, which will be held May 31 – June 4, in Chicago, IL.
May 21, 2024
·
2 min read
Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy
Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a research collaboration with the Food and Drug Administration (FDA).
April 8, 2024
·
3 min read
Aster Insights, ORIEN to Present Abstract on Young Onset Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
Aster Insights today announced the company and members of the Oncology Research Information Exchange Network® (ORIEN) will be presenting at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, which will be held January 18-20, 2024 in San Francisco, CA.
January 16, 2024
·
2 min read
ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform
Aster Insights today announced upcoming research presentations at the American Society of Hematology’s (ASH) 65th Annual Meeting December 9-12 in San Diego, CA.
December 8, 2023
·
2 min read
M2GEN Rebrands to Aster Insights
M2GEN today announced it is rebranding, changing the company’s name to Aster Insights™.
April 14, 2023
·
3 min read
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
Business
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation and Aster Insights today announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes associated with cancer.
April 27, 2023
·
6 min read
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
1 of 6,733
Next
